Never-smokers, never-drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancers

Head and Neck

Volumn 32, Issue 4, 2010, Pages 499-503

  Harris, Stephen L ^a   Kimple, Randall J ^a   Hayes, D Neil ^a,b   Couch, Marion E ^a,b   Rosenman, Julian G ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Head and neck squamous cell carcinoma; Never drinker; Never smoker; Radiotherapy; Young

Indexed keywords

ADULT; ARTICLE; CANCER RELAPSE; DISEASE FREE SURVIVAL; DRINKING BEHAVIOR; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; SEX RATIO; SMOKING; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOLISM; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SMOKING; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77949345498     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21220     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-619.
3. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-1849.
4. Golas SM. Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol 2007;35:98-108.
5. Schantz SP, Yu G-P. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002;128:268-274.
6. Annertz K, Anderson H, Biorklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002;101:95-99.
7. Jin YT, Myers J, Tsai ST, Goepfert H, Batsakis JG, el-Naggar AK. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol 1999;35:251-256.
8. Sturgis E, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer 2007;110:1429-1435.
9. Garavello W, Spreafico R, Gaini RM. Oral tongue cancer in young patients: a matched analysis. Oral Oncol 2007;43:894-897.
10. Pytynia KB, Grant JR, Etzel CJ, Roberts D, Wei Q, Sturgis EM. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. Arch Otolaryngol Head Neck Surg 2004;130:869-873.
11. Popovtzer A, Shpitzer T, Bahar G, Marshak G, Ulanovski D, Feinmesser R. Squamous cell carcinoma of the oral tongue in young patients. Laryngoscope 2004;114:915-917.
12. Vargas H, Pitman K, Galati L. More aggressive behavior of squamous cell carcinoma of the anterior tongue in young women. Laryngoscope 2000;110:1623-1626.
13. Gilroy J, Morris CG, Amdur RJ, Mendenhall WM. Impact of young age on prognosis for head and neck cancer: a matched-pair analysis. Head Neck 2005;27:269-273.
14. Verschurr H, Irish JC, Pintile M. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:249-258.
15. Dahlstrom K, Little JA, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker - never drinkers: a descriptive epidemiologic study. Head Neck 2008;30:75-84.
16. Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Nonsmoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis 2007;13:239-243.
17. Wiseman S, Swede H, Loree TR. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 2003;10:551-557.
18. O'Regan EM, Timon C, Sheils O, Codd M, O'Leary JJ, Toner M. Squamous cell carcinoma of the head and neck in young Irish adults. Br J Oral Maxillofac Surg 2006;44:203-206.
19. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Head Neck Surg 2000;122:44-51.
20. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. ppxiv, 421.
21. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Annertz K, Anderson H, Wennerberg J. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002;101:95-99.
23. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-2623.
24. Frisch M, Hjalgrim H, Jæger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000;11:489-495.
25. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003;95:1772-1783.
26. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006;24:2606-2611.
27. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006;24:5630-5636.
28. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;26:3128-3137.
29. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-269.
30. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001;125:1-9.
31. Singh B, Pfister DG. Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge? J Clin Oncol 2008;26:3114-3116.
32. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500.
33. Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-7356.
34. Wreesmann VB, Shi W, Thaler HT, et al. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 2004;22:3965-3972.
35. Poeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007;357:2552-2561.
36. Reimers N, Kasper HU, Klussmann JP. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007;120:1731-1738.
37. Smith EM, Wang D, Rubenstein LM, Morris WA, Turek LP, Haugen TH. Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev 2008;17:421-427.